QUOTE AND NEWS
Motley Fool  Jul 25  Comment 
The first CAR-T therapy recently won a unanimous thumbs up for approval. But that doesn't mean CAR-T stocks are out of the woods just yet.
FiercePharma  Jul 24  Comment 
In a long-running patent fight over Lovenox copycats, Amphastar finally prevailed Friday, with a U.S. jury verdict against Momenta and Sandoz. Cue a sigh of relief for Amphastar: It might have owed more than $900 million in damages.
FiercePharma  Jul 21  Comment 
Cyndi Lauper is back to star in another round of Novartis’ psoriasis marketing. The '80s pop music icon, who last year partnered with the Swiss pharma giant and the National Psoriasis Foundation on a disease-awareness push, appears with two...
GenEng News  Jul 21  Comment 
The FDA has accepted for review the Biologics License Application (BLA) of Amgen and Novartis for the migraine prevention treatment Aimovig™ (erenumab). Aimovig, also known as AMG 334, is indicated for the prevention of migraine in patients...
FierceBiotech  Jul 20  Comment 
Sanofi Genzyme's and Novartis’ venture arms have backed NeuroVia, an upstart that wants to help treat the rare CNS disorder X-linked adrenoleukodystrophy.
GenEng News  Jul 19  Comment 
A chimeric antigen receptor T-cell (CAR-T) therapy for glioblastoma (GBM) successfully crossed the blood–brain barrier to reach tumors in the brain, appeared safe, and reduced levels of its epidermal growth factor variant III (EGFRvIII) tumor...




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki